{"id":33252,"date":"2026-09-18T20:29:58","date_gmt":"2026-09-19T00:29:58","guid":{"rendered":"https:\/\/www.ipoboutique.com\/blog\/?p=33252"},"modified":"2026-09-18T20:29:58","modified_gmt":"2026-09-19T00:29:58","slug":"ipo-summary-post-labor-day-ipo-window-opens-with-a-thud","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-summary-post-labor-day-ipo-window-opens-with-a-thud\/","title":{"rendered":"IPO Summary: Post-Labor Day IPO Window Opens With a Thud"},"content":{"rendered":"<h2 class=\"break-words\">Orion180 Insurance Group (OIG): Investors Pushback on Insurance Valuations, OIG Opens Below Issue<\/h2>\n<p>Orion180 Insurance Group (OIG US)\u00a0IPO had plenty of demand\u2014but not enough at the price. The specialty insurer priced 20.0 million shares at $12.00, a full $3 below the original $15\u2013$17 range, and opened at $11.50. The stock remained relatively tight throughout the session before closing at $11.66, after briefly touching $11.90 in the final five minutes of trading. The result provides a clear read-through on investor appetite for insurance IPOs: demand was there, but valuation proved to be the sticking point.<\/p>\n<p data-start=\"4001\" data-end=\"4308\">Orion180&#8217;s first-day performance was disappointing relative to the company&#8217;s growth profile and the level of investor interest indicated during the roadshow. The IPO was ultimately well oversubscribed, but heavily price-sensitive, and the $12 pricing concession still failed to produce a positive debut.<\/p>\n<p data-start=\"4310\" data-end=\"4639\">The key takeaway is that investors did not reject the Orion180 story; they rejected the initial valuation framework. With the stock now trading below the IPO price, the next several weeks will be important in determining whether the company&#8217;s strong growth and profitability can begin to attract investors at the lower valuation.<\/p>\n<p data-start=\"4641\" data-end=\"4817\">The result also puts additional focus on Bamboo&#8217;s upcoming IPO. After Orion180&#8217;s experience, investors may demand greater valuation discipline from the next insurance offering.<\/p>\n<h2 class=\"break-words\">Electra Therapeutics (ETRA): Biotech IPO Finds Little Aftermarket Support Despite Upsize<\/h2>\n<p>Electra Therapeutics (ETRA US)\u00a0entered the public markets with what appeared to be a supportive setup: improving biotech IPO sentiment, a well-received roadshow and an order book that ultimately finished more than four times oversubscribed. But strong headline demand failed to translate into aftermarket support, as Electra Therapeutics (ETRA) opened flat and spent most of the session under pressure, closing at its lows.<\/p>\n<p data-start=\"517\" data-end=\"845\">Electra priced 23.33 million shares at $15.00, the midpoint of its original $14-$16 range and modestly above the 21.66 million shares initially marketed in the prospectus. The upsizing suggested meaningful investor interest heading into pricing, but the final outcome proved disappointing given the level of reported demand.<\/p>\n<p data-start=\"847\" data-end=\"1092\">The stock opened at $15.00, essentially unchanged from the IPO price, and briefly traded as high as $15.50 during the first 10 minutes. That early strength quickly faded, however, with shares falling below issue price shortly thereafter. The selling pressure remained steady throughout the session, with ETRA unable to establish a meaningful bid above the IPO price. The stock ultimately finished at $13.25, down 11.7% from the $15.00 IPO price, and at the session low. The weak trading was particularly notable because the deal had been upsized and the order book reportedly finished north of four-times covered.<\/p>\n<h2 data-start=\"847\" data-end=\"1092\">American Saving Banks Provides another Regional Bank Win<\/h2>\n<p><strong>American Savings Bank (ASBH)<\/strong> delivered a solid debut, providing another data point for the continued stability of regional bank IPOs. The company priced 8.05 million shares, upsized from 7.49 million, at $16.00 per share, the midpoint of its marketed range. Shares opened at $17.00, a 6.3% gain at first trade, and held that level through the close of the first session. Momentum continued into the remainder of the week, with ASBH reaching a high of $18.00 before ending Friday\u2019s session at $17.57, or 9.8% above its IPO price. The performance adds to a broader pattern of relatively steady trading among recent regional bank IPOs, which have continued to demonstrate investor demand and more measured post-IPO price action compared with some of the higher-volatility segments of the new-issue market. For American Savings Bank, the debut provides an encouraging start as investors assess the Hawaii-focused lender\u2019s growth prospects, profitability and balance-sheet profile as a newly public company.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orion180 Insurance Group (OIG): Investors Pushback on Insurance Valuations, OIG Opens Below Issue Orion180 Insurance Group (OIG US)\u00a0IPO had plenty of demand\u2014but not enough at the price. The specialty insurer priced 20.0 million shares at $12.00, a full $3 below the original $15\u2013$17 range, and opened at $11.50. The stock remained relatively tight throughout the[&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-33252","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/33252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=33252"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/33252\/revisions"}],"predecessor-version":[{"id":33253,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/33252\/revisions\/33253"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=33252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=33252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=33252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}